Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections
Centauri’s Alphamer platform has been uniquely developed as a powerful immune therapy that harnesses and empowers the body’s own naturally…
